MetLife Investment Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$778K Buy
52,578
+3,290
+7% +$48.7K ﹤0.01% 1449
2025
Q1
$883K Buy
49,288
+4,577
+10% +$82K ﹤0.01% 1427
2024
Q4
$779K Buy
44,711
+3,568
+9% +$62.2K ﹤0.01% 1549
2024
Q3
$576K Buy
41,143
+311
+0.8% +$4.35K ﹤0.01% 1709
2024
Q2
$336K Buy
40,832
+7,843
+24% +$64.5K ﹤0.01% 1941
2024
Q1
$254K Sell
32,989
-5,449
-14% -$42K ﹤0.01% 2063
2023
Q4
$346K Hold
38,438
﹤0.01% 1909
2023
Q3
$344K Hold
38,438
﹤0.01% 1856
2023
Q2
$590K Buy
38,438
+5,931
+18% +$91.1K ﹤0.01% 1586
2023
Q1
$731K Hold
32,507
0.01% 1409
2022
Q4
$684K Hold
32,507
0.01% 1437
2022
Q3
$801K Hold
32,507
0.01% 1308
2022
Q2
$788K Sell
32,507
-1,292
-4% -$31.3K 0.01% 1344
2022
Q1
$871K Buy
33,799
+12,475
+59% +$321K 0.01% 1420
2021
Q4
$662K Hold
21,324
0.01% 1343
2021
Q3
$517K Hold
21,324
﹤0.01% 1501
2021
Q2
$311K Hold
21,324
﹤0.01% 1865
2021
Q1
$532K Buy
+21,324
New +$532K ﹤0.01% 1490
2020
Q4
Sell
-21,324
Closed -$394K 2312
2020
Q3
$394K Buy
21,324
+2,482
+13% +$45.8K ﹤0.01% 1496
2020
Q2
$385K Hold
18,842
﹤0.01% 1523
2020
Q1
$275K Hold
18,842
﹤0.01% 1518
2019
Q4
$268K Hold
18,842
﹤0.01% 1817
2019
Q3
$218K Hold
18,842
﹤0.01% 1897
2019
Q2
$379K Hold
18,842
﹤0.01% 1648
2019
Q1
$426K Hold
18,842
﹤0.01% 1555
2018
Q4
$426K Hold
18,842
0.01% 1464
2018
Q3
$541K Hold
18,842
0.01% 1485
2018
Q2
$514K Buy
18,842
+2,439
+15% +$66.5K 0.01% 1395
2018
Q1
$367K Hold
16,403
﹤0.01% 1564
2017
Q4
$346K Buy
+16,403
New +$346K ﹤0.01% 1626